✦ LIBER ✦

Is there hope for Crohn's disease patients with anorectal/vaginal fistulas?

✍ Scribed by Harold L. Greenberg

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 113 KB
Volume: 3
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.3780030214

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adalimumab for the treatment of fistulas

Adalimumab for the treatment of fistulas in patients with Crohn's disease

✍ Steven N. Fine 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB 👁 2 views

Treatment of persistent perineal sinus w

Treatment of persistent perineal sinus with vaginal fistula following proctocolectomy for Crohn's disease

✍ M. W. N. Ward; B. G. Morgan; C. G. Clark 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB 👁 2 views

## Abstract The utilization of a myocutaneous flap based on the gracilis muscle is described in two patients who had a persistent perineal sinus following proctocolectomy for Crohn's disease. In each case the posterior vaginal wall had eroded to form a fistula. This flap provided a cutaneous surfac

Is laparoscopic surgery for most, a few,

Is laparoscopic surgery for most, a few, or no patients with Crohn's disease?

✍ Dr. Barry Salky 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 1 views

Effects of fistula on healthcare costs a

Effects of fistula on healthcare costs and utilization for patients with Crohn's disease treated in a managed care environment

✍ Russell D. Cohen; Heidi C. Waters; Boxiong Tang; Mirza I. Rahman 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

## Background: Fistulas are a common complication of crohn's disease (cd) and are difficult to treat effectively. this study aimed to assess the effects of fistula on annual costs of healthcare and resource utilization for patients with cd. ## Methods: A retrospective analysis, using the pharmetr

Ciprofloxacin or metronidazole for the t

Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: A randomized, double-blind, placebo-controlled pilot study

✍ Kelvin T. Thia; Uma Mahadevan; Brian G. Feagan; Cindy Wong; Alan Cockeram; Alain 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 1 views

Background: Although metronidazole and ciprofloxacin are used to treat perianal Crohn's disease (CD), no placebo-controlled trials have been performed. ## Methods: We performed a placebo-controlled pilot trial to evaluate the efficacy and safety of metronidazole and ciprofloxacin in patients with

Seroreactivity to microbial components i

Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients

✍ Maria Papp; Istvan Altorjay; Gary L. Norman; Zakera Shums; Karoly Palatka; Zsuzs 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 1 views

Background: Antibodies directed against Saccharomyces cerevisiae (ASCA), perinuclear components of neutrophils (pANCA), and porin protein C of Escherichia coli (anti-OmpC) are reported to be associated with disease phenotype and may be of diagnostic importance in inflammatory bowel disease (IBD). Si